Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)

Enrolling by invitationOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2030

Conditions

Graft Vs Host DiseaseInflammatory Bowel DiseasesFunctional Gastrointestinal Disorders

Trial Locations (4)

Seattle Children's Hospital, Seattle

Massachusetts General Hospital, Boston

Boston Children's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors

lead

Boston Children's Hospital

OTHER